This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Manuela Polydoro Ofengeim: Innovator in Tau-Related Disease Research
Introduction
Manuela Polydoro Ofengeim is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of tau-related diseases. Her innovative work has led to the development of valuable compositions and methods aimed at decreasing tau expression.
Latest Patents
Manuela holds a patent for "Compositions and methods for decreasing tau expression." This patent outlines compositions and methods that effectively reduce tau mRNA and protein expression. These advancements are crucial for treating tau-related diseases and disorders, showcasing her commitment to improving health outcomes.
Career Highlights
Throughout her career, Manuela has been associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
One of her notable collaborators is Jan Weiler, with whom she has worked closely on various projects. Their partnership exemplifies the importance of teamwork in advancing scientific research.
Conclusion
Manuela Polydoro Ofengeim's contributions to the field of tau-related disease research are commendable. Her innovative patent and collaboration with esteemed colleagues highlight her dedication to improving medical treatments.